|
Norris Medicines Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
15.95 Cr.
|
P/BV
|
-1.08
|
Book Value (Rs.)
|
-14.79
|
|
52 Week High/Low (Rs.)
|
25/14
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
29/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 |
| Diluted EPS (Rs.) | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 |
| Cash EPS (Rs.) | -0.70 | -0.61 | -1.13 | -2.63 | -4.33 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -14.98 | -13.73 | -12.54 | -10.77 | -7.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -14.98 | -13.73 | -12.54 | -10.77 | -7.49 |
| Revenue From Operations / Share (Rs.) | 5.86 | 5.68 | 8.42 | 9.51 | 12.34 |
| PBDIT / Share (Rs.) | -0.20 | -0.15 | 0.94 | -0.04 | -1.70 |
| PBIT / Share (Rs.) | -0.74 | -0.73 | 0.30 | -0.70 | -2.38 |
| PBT / Share (Rs.) | -1.19 | -1.11 | -1.20 | -2.20 | -4.02 |
| Net Profit / Share (Rs.) | -1.25 | -1.20 | -1.76 | -3.29 | -5.00 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -3.46 | -2.77 | 11.20 | -0.48 | -13.80 |
| PBIT Margin (%) | -12.68 | -12.91 | 3.67 | -7.44 | -19.25 |
| PBT Margin (%) | -20.24 | -19.48 | -14.27 | -23.14 | -32.59 |
| Net Profit Margin (%) | -21.26 | -21.05 | -20.93 | -34.57 | -40.50 |
| Return on Capital Employeed (%) | -20.17 | -14.67 | 5.13 | -9.49 | -29.14 |
| Return On Assets (%) | -8.96 | -8.36 | -12.78 | -22.99 | -25.07 |
| Long Term Debt / Equity (X) | -1.25 | -1.36 | -1.48 | -1.69 | -2.09 |
| Total Debt / Equity (X) | -1.45 | -1.36 | -1.48 | -1.69 | -2.09 |
| Asset Turnover Ratio (%) | 0.41 | 0.40 | 0.59 | 0.55 | 0.60 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.62 | 0.66 | 0.63 | 0.62 | 0.70 |
| Quick Ratio (X) | 0.21 | 0.19 | 0.22 | 0.27 | 0.26 |
| Inventory Turnover Ratio (X) | 1.38 | 0.83 | 1.15 | 0.94 | 2.09 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -0.45 | -0.42 | 0.62 | -0.03 | -1.04 |
| Interest Coverage Ratio (Post Tax) (%) | -1.82 | -2.21 | -0.16 | -1.20 | -2.04 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 38.20 | 32.05 | 28.78 | 52.77 | 21.95 |
| EV / Net Operating Revenue (X) | 6.56 | 5.69 | 3.44 | 5.59 | 1.79 |
| EV / EBITDA (X) | -189.57 | -204.76 | 30.72 | -1144.58 | -12.98 |
| MarketCap / Net Operating Revenue (X) | 2.86 | 2.40 | 1.24 | 3.68 | 0.52 |
| Price / BV (X) | -1.12 | -0.99 | -0.83 | -3.24 | -0.86 |
| Price / Net Operating Revenue (X) | 2.86 | 2.40 | 1.24 | 3.68 | 0.52 |
| EarningsYield | -0.07 | -0.08 | -0.16 | -0.09 | -0.76 |
